These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 8691431)

  • 1. Mapping the aspartic acid binding site of Escherichia coli asparagine synthetase B using substrate analogs.
    Parr IB; Boehlein SK; Dribben AB; Schuster SM; Richards NG
    J Med Chem; 1996 Jun; 39(12):2367-78. PubMed ID: 8691431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic mechanism of Escherichia coli asparagine synthetase B.
    Boehlein SK; Stewart JD; Walworth ES; Thirumoorthy R; Richards NG; Schuster SM
    Biochemistry; 1998 Sep; 37(38):13230-8. PubMed ID: 9748330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of cysteine-523 in the aspartate binding site of Escherichia coli asparagine synthetase B.
    Boehlein SK; Walworth ES; Schuster SM
    Biochemistry; 1997 Aug; 36(33):10168-77. PubMed ID: 9254614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutamic acid gamma-monohydroxamate and hydroxylamine are alternate substrates for Escherichia coli asparagine synthetase B.
    Boehlein SK; Schuster SM; Richards NG
    Biochemistry; 1996 Mar; 35(9):3031-7. PubMed ID: 8608142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A convenient gHMQC-based NMR assay for investigating ammonia channeling in glutamine-dependent amidotransferases: studies of Escherichia coli asparagine synthetase B.
    Li KK; Beeson WT; Ghiviriga I; Richards NG
    Biochemistry; 2007 Apr; 46(16):4840-9. PubMed ID: 17397190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probing the mechanism of nitrogen transfer in Escherichia coli asparagine synthetase by using heavy atom isotope effects.
    Stoker PW; O'Leary MH; Boehlein SK; Schuster SM; Richards NG
    Biochemistry; 1996 Mar; 35(9):3024-30. PubMed ID: 8608141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic mechanism of asparagine synthetase from Vibrio cholerae.
    Fresquet V; Thoden JB; Holden HM; Raushel FM
    Bioorg Chem; 2004 Apr; 32(2):63-75. PubMed ID: 14990305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and activity of bisubstrate, transition-state analogues and competitive inhibitors of aspartate transcarbamylase.
    Grison C; Coutrot P; Comoy C; Balas L; Joliez S; Lavecchia G; Oliger P; Penverne B; Serre V; Hervé G
    Eur J Med Chem; 2004 Apr; 39(4):333-44. PubMed ID: 15072842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of beta-ketophosphonate analogs of glutamyl and glutaminyl adenylate, and selective inhibition of the corresponding bacterial aminoacyl-tRNA synthetases.
    Balg C; Blais SP; Bernier S; Huot JL; Couture M; Lapointe J; Chênevert R
    Bioorg Med Chem; 2007 Jan; 15(1):295-304. PubMed ID: 17049867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-state inhibitors of E. coli aspartate transcarbamoylase that prevent the allosteric transition.
    Heng S; Stieglitz KA; Eldo J; Xia J; Cardia JP; Kantrowitz ER
    Biochemistry; 2006 Aug; 45(33):10062-71. PubMed ID: 16906764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analogs of L-aspartic acid in chemotherapy for cancer.
    Jayaram HN; Cooney DA
    Cancer Treat Rep; 1979 Jun; 63(6):1095-108. PubMed ID: 38003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutagenesis and chemical rescue indicate residues involved in beta-aspartyl-AMP formation by Escherichia coli asparagine synthetase B.
    Boehlein SK; Walworth ES; Richards NG; Schuster SM
    J Biol Chem; 1997 May; 272(19):12384-92. PubMed ID: 9139684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of action of Escherichia coli phosphoribosylaminoimidazolesuccinocarboxamide synthetase.
    Nelson SW; Binkowski DJ; Honzatko RB; Fromm HJ
    Biochemistry; 2005 Jan; 44(2):766-74. PubMed ID: 15641804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspartyl phosphonates and phosphoramidates: the first synthetic inhibitors of bacterial aspartate-semialdehyde dehydrogenase.
    Cox RJ; Gibson JS; Mayo Martín MB
    Chembiochem; 2002 Sep; 3(9):874-86. PubMed ID: 12210989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Asparagine synthetase activity in pediatric acute lymphoblastic leukemia].
    Jiang H; Gu LJ; Xue HL; Tang JY; Chen J; Pan C; Chen J
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Aug; 8(4):272-4. PubMed ID: 16923354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Aspartyladenylate analog--effective inhibitor of asparagine synthetase].
    Zhukov IuN; Biriukov AI; Khomutov RM
    Bioorg Khim; 1988 Jul; 14(7):969-72. PubMed ID: 2903747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asparagine synthetase chemotherapy.
    Richards NG; Kilberg MS
    Annu Rev Biochem; 2006; 75():629-54. PubMed ID: 16756505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient expression, purification, and characterization of C-terminally tagged, recombinant human asparagine synthetase.
    Ciustea M; Gutierrez JA; Abbatiello SE; Eyler JR; Richards NG
    Arch Biochem Biophys; 2005 Aug; 440(1):18-27. PubMed ID: 16023613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of L-asparagine synthetase, in vitro.
    Cooney DA; Driscoll JS; Milman HA; Jayaram HN; Davis RD
    Cancer Treat Rep; 1976 Oct; 60(10):1493-557. PubMed ID: 14784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and analysis of inhibitors of bacterial aspartate semialdehyde dehydrogenase.
    Cox RJ; Gibson JS; Hadfield AT
    Chembiochem; 2005 Dec; 6(12):2255-60. PubMed ID: 16261551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.